NCT02478840View on ClinicalTrials.gov

Evaluation of Long-term Efficacy of Treatment With Lamazym

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Alpha-Mannosidosis
Interventions
DRUG

Lamazym

recombinant human alpha-mannosidase

Trial Locations (1)

DK-2100

Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen

All Listed Sponsors
lead

Zymenex A/S

INDUSTRY

NCT02478840 - Evaluation of Long-term Efficacy of Treatment With Lamazym | Biotech Hunter | Biotech Hunter